November 18, 2024 · Form 4 insider transaction
Renninger Robert bought 3,651 shares of Athira Pharma, Inc. at $0.55 per share, a transaction worth $2.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 46 days after the transaction.
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of May 20, 2024 through November 18, 2024. This transaction is also exempt under Rule 16b-3(c).; The Purchase Period ended November 18, 2024 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began May 20, 2024.; In accordance with the ESPP, these shares were purchased based on 85% of the closing price on November 18, 2024.